MBIO
MUSTANG BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.37
−0.90%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$140
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$140
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -80.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$140 | -$0.16 | Beat 99.89% | — |
| May 5, 2026 | -$140 | -$0.14 | Beat 99.90% | — |
| Mar 19, 2026 | — | -$0.08 | — | — |
| Nov 7, 2025 | — | -$0.07 | — | — |
| Aug 8, 2025 | — | -$0.19 | — | — |
| May 14, 2025 | — | -$0.05 | — | — |
| Mar 24, 2025 | -$5.50 | -$38 | Miss -590.00% | — |
| Nov 8, 2024 | -$6.50 | -$2.00 | Beat 69.23% | — |
| May 15, 2024 | -$0.87 | -$23 | Miss -2543.68% | — |
| Mar 11, 2024 | -$84 | -$36 | Beat 57.74% | $2.9M |
| Nov 14, 2023 | -$94 | -$62 | Beat 34.57% | — |
| Aug 14, 2023 | -$104 | -$100 | Beat 3.38% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026